Composite Glucose and C-Peptide Endpoints Show Early Efficacy in Recent-Onset Type 1 Diabetes (T1D) Clinical Trials

被引：0
|
作者：
Jacobsen, Laura M.
Cuthbertson, David D.
Haller, Michael J.
Ismail, Heba M.
Sims, Emily K.
Gitelman, Stephen E.
Wherrett, Diane K.
Moran, Antoinette
Atkinson, Mark A.
Pugliese, Alberto
Gottlieb, Peter
Sosenko, Jay
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-825-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
825-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Modifiers of C-Peptide Change during the Progression to Type 1 Diabetes (T1D) in the TrialNet Pathway to Prevention Study
    Ismail, Heba M.
    Cleves, Mario A.
    Gitelman, Stephen E.
    Skyler, Jay S.
    Steck, Andrea
    Rodriguez, Henry
    Atkinson, Mark A.
    Nathan, Brandon M.
    Redondo, Maria Jose
    Herold, Kevan C.
    Palmer, Jerry P.
    Evans-Molina, Carmella
    Dimeglio, Linda
    Sosenko, Jay M.
    DIABETES, 2019, 68
  • [22] Efficacy of New-Onset Type 1 Diabetes (T1D) Intervention Trials: Variation in 1-Year Outcomes
    Haller, Michael J.
    Greco, Madison N.
    Schatz, Desmond
    Atkinson, Mark A.
    Brusko, Todd M.
    Mathews, Clayton E.
    Jacobsen, Laura M.
    Herold, Kevan C.
    Gitelman, Stephen E.
    Krischer, Jeffrey
    Bundy, Brian N.
    DIABETES, 2019, 68
  • [23] Comparing Beta Cell Preservation Across Clinical Trials in Recent-Onset Type 1 Diabetes
    Jacobsen, Laura M.
    Bundy, Brian N.
    Greco, Madison N.
    Schatz, Desmond A.
    Atkinson, Mark A.
    Brusko, Todd M.
    Mathews, Clayton E.
    Herold, Kevan C.
    Gitelman, Stephen E.
    Krischer, Jeffrey P.
    Haller, Michael J.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (12) : 948 - 953
  • [24] Effect of Oral Insulin on Early Combined Glucose and C-Peptide Endpoints in Individuals at High-Risk for Type 1 Diabetes
    Triolo, Taylor M.
    Jacobsen, Laura M.
    Cuthbertson, David
    Sims, Emily K.
    Ismail, Heba M.
    Redondo, Maria J.
    Lundgren, Markus
    DiMeglio, Linda A.
    Gottlieb, Peter A.
    Atkinson, Mark A.
    Krischer, Jeffrey P.
    Schatz, Desmond A.
    Sosenko, Jay M.
    PEDIATRIC DIABETES, 2024, 2024
  • [25] The Association of C-Peptide with BMI at the Diagnosis of Type 1 Diabetes (T1D) in Children Participating in the Diabetes Prevention Trial-Type 1 (DPT-1)
    Sosenko, Jay M.
    Evans-Molina, Carmella
    Dimeglio, Linda A.
    Rafkin, Lisa E.
    Liu, Yuk-Fun
    Skyler, Jay S.
    Palmer, Jerry P.
    DIABETES, 2016, 65 : A341 - A341
  • [26] Low Frequency of Activated Tregs in T1D May Result in Earlier Onset of Diabetes and Lower Residual C-Peptide
    Okubo, Yoshiaki
    Washer, Sophie L. L.
    Faustman, Denise L.
    DIABETES, 2015, 64 : A61 - A61
  • [27] Correction to: Validation in the general population of a C-peptide estimate equation to measure beta cell function in recent-onset type 1 diabetes
    Joanna Wang
    Naiara Bediaga
    Roberto Mallone
    Etienne Larger
    Leonard C. Harrison
    John M. Wentworth
    Acta Diabetologica, 2021, 58 : 119 - 119
  • [28] NICOTINAMIDE INCREASES C-PEPTIDE SECRETION IN PATIENTS WITH RECENT ONSET TYPE-1 DIABETES
    POZZILLI, P
    VISALLI, N
    GHIRLANDA, G
    MANNA, R
    ANDREANI, D
    DIABETIC MEDICINE, 1989, 6 (07) : 568 - 572
  • [29] Celiac Autoimmunity Has No Effect on C-Peptide Levels at Onset and Remission in Children With T1D
    Cristaldi, Christina L.
    Libman, Ingrid
    Arena, Vincent C.
    Huang, Yihe
    Becker, Dorothy J.
    DIABETES, 2013, 62 : A353 - A353
  • [30] Glucose-Independent Racial Disparity in HbA1c Is Present at Onset of Type 1 Diabetes (T1D)
    Alaqeel, Aqeel
    Chalew, Stuart
    DIABETES, 2019, 68
12345